Diam »

Crispr Therapeutics shares owned by Diam

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Diam from 13F filings

Historical chart of Diam investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Diam consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Diam

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 27k 68.16
2023-12-31 $1.7M 27k 64.30
2022-03-31 $6.0k 100 60.00
2021-12-31 $7.0k 100 70.00
2021-09-30 $11k 100 110.00
2021-06-30 $48k 300 160.00
2021-03-31 $512k 4.2k 121.62
2020-12-31 $1.8M 11k 157.74
2020-09-30 $931k 11k 83.63